Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 26;15(11):2536.
doi: 10.3390/pharmaceutics15112536.

Photodynamic Therapy for X-ray-Induced Radiation-Resistant Cancer Cells

Affiliations

Photodynamic Therapy for X-ray-Induced Radiation-Resistant Cancer Cells

Hiromu Ito et al. Pharmaceutics. .

Abstract

Radiotherapy, in which X-rays are commonly used, is one of the most effective procedures for treating cancer. However, some cancer cells become resistant to radiation therapy, leading to poor prognosis. Therefore, a new therapeutic method is required to prevent cancer cells from acquiring radiation resistance. Photodynamic therapy (PDT) is a cancer treatment that uses photosensitizers, such as porphyrin compounds, and low-powered laser irradiation. We previously reported that reactive oxygen species (ROS) derived from mitochondria induce the expression of a porphyrin transporter (HCP1) and that laser irradiation enhances the cytotoxic effect. In addition, X-ray irradiation induces the production of mitochondrial ROS. Therefore, radioresistant cancer cells established with continuous X-ray irradiation would also overexpress ROS, and photodynamic therapy could be an effective therapeutic method. In this study, we established radioresistant cancer cells and examined the therapeutic effects and mechanisms with photodynamic therapy. We confirmed that X-ray-resistant cells showed overgeneration of mitochondrial ROS and elevated expression of HCP1, which led to the active accumulation of porphyrin and an increase in cytotoxicity with laser irradiation. Thus, photodynamic therapy is a promising treatment for X-ray-resistant cancers.

Keywords: HCP1; radioresistance; reactive oxygen species.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Cell viability after a single dose irradiation of X-ray was estimated and compared between the continual X-ray-irradiated RGK1 cells and the non-treated control cells by colony formation assay. Statistical significance was tested by Student’s t-test. n = 3, mean ± S.D., ** p < 0.01.
Figure 2
Figure 2
Intracellular ROS production level was estimated and compared between the X-ray resistant cells and the control cells. (A) representative images of cells stained with HPF and MitoTrackerTM Red CMXRos fluorescence dye. Scale bar: 50 μm. (B) the relative fluorescence intensity of HPF. (C) the relative fluorescence intensity of MitoSOXTM Mitochondrial Superoxide Indicators. Statistical significance was tested by Student’s t-test. n = 120 for control samples in HPF experiment, n = 147 for X-ray resistant samples in HPF experiment, and n = 12 for MitoSOXTM experiment. Mean ± S.D., ** p < 0.01.
Figure 3
Figure 3
The expression levels of HIF-1α and HCP1 in the X-ray-resistant cells and control cells were analyzed by Western blotting. (A) representative images of blotting bands. (B) the relative expressions of HCP1. (C) the relative expressions of HIF-1α. Statistical significance was tested by Student’s t-test. n = 10, mean ± S.D., * p < 0.05. The uncropped blots are shown in Figure S1.
Figure 4
Figure 4
Comparison of intracellular porphyrin accumulation levels by measurements of porphyrin fluorescence in cell lysates. Statistical significance was tested by Tukey’s HSD test. n = 6, mean ± S.D., ** p < 0.01.
Figure 5
Figure 5
Relative cell viability with or without laser irradiation at 2 J/cm2 in the X-ray-resistant cells and the control cells. The viability is normalized with non-laser irradiated samples. Statistical significance was tested by Tukey’s HSD test. n = 6, mean ± S.D., ** p < 0.01.

Similar articles

Cited by

References

    1. Lalo R., Zekja I., Kamberi F. Association of Cardiovascular Disease Risk and Health-Related Behaviors in Stroke Patients. Int. J. Environ. Res. Public Health. 2023;20:3693. doi: 10.3390/ijerph20043693. - DOI - PMC - PubMed
    1. Toyoda K., Yasaka M., Iwade K., Nagata K., Koretsune Y., Sakamoto T., Uchiyama S., Gotoh J., Nagao T., Yamamoto M., et al. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: A prospective, multicenter, observational study. Stroke. 2008;39:1740–1745. doi: 10.1161/STROKEAHA.107.504993. - DOI - PubMed
    1. Alam M., Goldberg L.H. Serious Adverse Vascular Events Associated With Perioperative Interruption of Antiplatelet and Anticoagulant Therapy. Dermatolog. Surg. 2002;28:992–998. doi: 10.1046/j.1524-4725.2002.02085.x. - DOI - PubMed
    1. Louison S., Gabrielle P.H., Soudry A., Meillon C., Blanc J., Béal G., Arsène S., Le Mer Y., Berrod J.P., Kodjikian L., et al. Perioperative risk of bleeding with antithrombotic agents in macular surgery: A national, prospective, multicentre study. Acta Ophthalmol. 2020;98:e991–e997. doi: 10.1111/aos.14434. - DOI - PubMed
    1. Vargason A.M., Anselmo A.C., Mitragotri S. The evolution of commercial drug delivery technologies. Nat. Biomed. Eng. 2021;5:951–967. doi: 10.1038/s41551-021-00698-w. - DOI - PubMed

LinkOut - more resources